Literature DB >> 1472336

Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity.

C A Kemper1, A R Zolopa, J R Hamilton, M Fenstersheib, G Bhatia, S C Deresinski.   

Abstract

OBJECTIVES: To determine the prevalence of measles (rubeola) immunity in a group of HIV-1-infected adults and to examine predictors of measles seronegativity in this population.
SETTING: County hospital outpatient clinic and public-health department early HIV intervention clinic. PATIENTS: A total of 262 HIV-infected adults presenting to outpatient clinics between September 1990 and January 1991.
INTERVENTIONS: Patients were screened for the presence of measles immunoglobulin G antibody, as measured by an enzyme-linked immunosorbent assay (ELISA). Pertinent clinical and immunologic information was recorded. Univariate and multivariate analyses were performed to identify possible risk factors for measles seronegativity. MAIN OUTCOME MEASURE: Measles seronegativity, as defined by a lack of detectable antibody (ELISA predicted index value < 1.0).
RESULTS: Thirteen (5%) patients lacked serologic evidence of immunity. Risk factors for measles seronegativity included year of birth in 1957 or later, Caucasian (non-Hispanic) race and oral hairy leukoplakia. Factors associated with progressive HIV disease (other than hairy leukoplakia) were not associated with a lack of existing immunity.
CONCLUSIONS: A high prevalence (95%) of measles antibody was found in this large group of HIV-infected adults. Young, white individuals born in 1957 or later were at the greatest risk for measles seronegativity, but declining immunity due to progressive HIV infection did not appear to be associated with a lack of antibody. Self-reported histories of measles infection or immunization were not reliable predictors of measles immunity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1472336     DOI: 10.1097/00002030-199211000-00013

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

Review 1.  Vaccination in HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Mark R Wallace
Journal:  AIDS Patient Care STDS       Date:  2014-07-16       Impact factor: 5.078

Review 2.  Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.

Authors:  Solen Kernéis; Odile Launay; Clément Turbelin; Frédéric Batteux; Thomas Hanslik; Pierre-Yves Boëlle
Journal:  Clin Infect Dis       Date:  2014-01-10       Impact factor: 9.079

3.  Decrease in Numbers of Naive and Resting B Cells in HIV-Infected Kenyan Adults Leads to a Proportional Increase in Total and Plasmodium falciparum-Specific Atypical Memory B Cells.

Authors:  Anne E Frosch; Oludare A Odumade; Justin J Taylor; Kathleen Ireland; George Ayodo; Bartholomew Ondigo; David L Narum; John Vulule; Chandy C John
Journal:  J Immunol       Date:  2017-05-19       Impact factor: 5.422

4.  Surprisingly Low Levels of Measles Immunity in Persons With HIV: A Seroprevalence Survey in a United States HIV Clinic.

Authors:  Lindsey Rearigh; Jennifer O'Neill; Maureen Kubat; Harlan Sayles; Susan Swindells; Sara H Bares
Journal:  Open Forum Infect Dis       Date:  2020-09-12       Impact factor: 3.835

5.  Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.

Authors:  C Schwarze-Zander; R Draenert; C Lehmann; M Stecher; C Boesecke; S Sammet; J C Wasmuth; U Seybold; D Gillor; U Wieland; T Kümmerle; C P Strassburg; A Mankertz; A M Eis-Hübinger; G Jäger; G Fätkenheuer; J R Bogner; J K Rockstroh; J J Vehreschild
Journal:  Epidemiol Infect       Date:  2016-10-26       Impact factor: 4.434

Review 6.  Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.

Authors:  Nancy F Crum-Cianflone; Eva Sullivan
Journal:  Infect Dis Ther       Date:  2017-08-05

7.  Low immunity against vaccine preventable diseases in Turkish HIV cohort

Authors:  Aslihan Candevir; Ferit Kuşcu; Figen Yildirim; Süheyla Kömür; Gönül Çiçek Şentürk; Ayşe Seza Inal; Fatma Eser; Salih Çetiner; Behice Kurtaran; Yeşim Taşova
Journal:  Turk J Med Sci       Date:  2021-10-21       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.